跳至主要内容
临床试验/ACTRN12620000831987
ACTRN12620000831987已完成未知

Magnetic Sentinel Lymph Node Mapping in Oral Squamous Cell Carcinoma: A Phase I Feasibility and Validity Clinical Trial

Central Adelaide Local Health Network trading as Royal Adelaide Hospital0 个研究点目标入组 15 人开始时间: 2020年8月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age 18 or older
  • - Willing to provide informed consent
  • - ECOG status 0-2
  • - Biopsy proven T1-T2 oral SCC (tongue, RMT, buccal mucosa, FOM, hard palate)
  • - Clinically and radiologically N0 neck on contrast enhanced CT or gadolinium enhanced MRI +/- (USS or FDG PET)
  • - No distant metastases
  • - Primary tumours amenable to surgical resection

排除标准

  • - Serious medical comorbidities or other contraindications to surgery +/- adjuvant therapy
  • - Advanced T-stage primary tumour (>T2)
  • - Primary tumours not amenable to surgical resection
  • - Previous HNSCC
  • - Previous head and neck radiotherapy at any time
  • - Lip involvement
  • - Allergy or Intolerance to iron oxide or dextran compounds
  • - Metal implant close to site of sentinel lymph node
  • - Iron overload disorder
  • - Standard contraindications to MRI scanning
  • - Pregnant or lactating women

研究者

发起方
Central Adelaide Local Health Network trading as Royal Adelaide Hospital

相似试验